1. Home
  2. IPI vs CLLS Comparison

IPI vs CLLS Comparison

Compare IPI & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intrepid Potash Inc

IPI

Intrepid Potash Inc

N/A

Current Price

$31.13

Market Cap

419.8M

Sector

Industrials

ML Signal

N/A

Logo Cellectis S.A.

CLLS

Cellectis S.A.

N/A

Current Price

$1.08

Market Cap

394.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IPI
CLLS
Founded
2000
1999
Country
United States
France
Employees
N/A
N/A
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
419.8M
394.4M
IPO Year
2007
2014

Fundamental Metrics

Financial Performance
Metric
IPI
CLLS
Price
$31.13
$1.08
Analyst Decision
Sell
Buy
Analyst Count
3
5
Target Price
★ $36.50
$4.83
AVG Volume (30 Days)
★ 163.8K
94.7K
Earning Date
11-03-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 105.14
N/A
EPS
★ 1.73
N/A
Revenue
★ $298,328,000.00
N/A
Revenue This Year
$13.45
N/A
Revenue Next Year
N/A
$10.70
P/E Ratio
$18.17
★ N/A
Revenue Growth
★ 17.13
N/A
52 Week Low
$22.55
$0.88
52 Week High
$50.34
$5.45

Technical Indicators

Market Signals
Indicator
IPI
CLLS
Relative Strength Index (RSI) 36.96 36.03
Support Level $30.36 $0.88
Resistance Level $36.20 $2.99
Average True Range (ATR) 1.06 0.10
MACD 0.13 0.06
Stochastic Oscillator 29.96 39.88

Price Performance

Historical Comparison
IPI
CLLS

About IPI Intrepid Potash Inc

Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, where the firm's production facilities are located.

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Share on Social Networks: